← GLOBUS MEDICAL INC GMED
Market Price
$85.87
Market Cap
$11.67B
P/E Ratio
21.91
Revenue (FY 2025)
↑16.7% YoY
$2.94B
3-Yr CAGR: 42.2%
Net Income
↑422.3% YoY
$537.87M
Net Margin: 18.3%
Free Cash Flow
↑45.3% YoY
$588.77M
FCF Yield: 5.05%
EPS (Diluted)
↑422.7% YoY
$3.92
Basic: $3.98
Return on Equity
Efficiency
11.8%
ROA: 822.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (GMED)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $564.0M | — | $429.3M | $104.3M | — | $1.08 | — | $171.9M | $131.0M | — |
| FY 2017 | $636.0M | +12.8% | $485.5M | $107.3M | +2.9% | $1.10 | +1.9% | $159.5M | $108.2M | -17.4% |
| FY 2018 | $713.0M | +12.1% | $553.6M | $156.5M | +45.8% | $1.54 | +40.0% | $181.6M | $121.9M | +12.7% |
| FY 2019 | $785.4M | +10.2% | $605.4M | $155.2M | -0.8% | $1.52 | -1.3% | $172.0M | $101.2M | -17.0% |
| FY 2020 | $789.0M | +0.5% | $571.6M | $102.3M | -34.1% | $1.01 | -33.6% | $198.8M | $135.1M | +33.5% |
| FY 2021 | $958.1M | +21.4% | $718.9M | $149.2M | +45.9% | $1.44 | +42.6% | $276.3M | $219.4M | +62.3% |
| FY 2022 | $1,022.8M | +6.8% | $759.1M | $190.2M | +27.5% | $1.85 | +28.5% | $178.5M | $104.4M | -52.4% |
| FY 2023 | $1,568.5M | +53.3% | $1,020.3M | $122.9M | -35.4% | $1.07 | -42.2% | $243.5M | $165.2M | +58.2% |
| FY 2024 | $2,519.4M | +60.6% | $1,483.9M | $103.0M | -16.2% | $0.75 | -29.9% | $520.6M | $405.2M | +145.2% |
| FY 2025 | $2,938.9M | +16.7% | $1,981.1M | $537.9M | +422.3% | $3.92 | +422.7% | $753.4M | $588.8M | +45.3% |
Valuation
Market Price
$85.87
Market Cap
$11.67B
Enterprise Value
N/A
P/E Ratio
21.91
P/B Ratio
2.55
FCF Yield
5.05%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
67.41%
Operating Margin
16.33%
Net Margin
18.30%
Return on Equity (ROE)
11.76%
Return on Assets (ROA)
822.10%
Asset Turnover
44.92x
Revenue 3-Yr CAGR
42.17%
Financial Health & Liquidity
Current Ratio
0.20
Cash Ratio
1.58
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$526.16M
Total Debt
N/A
Book Value / Share
$33.69
Cash Flow Efficiency
Operating Cash Flow
$753.45M
Capital Expenditures (CapEx)
$164.68M
Free Cash Flow
$588.77M
OCF / Revenue
25.64%
FCF / Revenue
20.03%
FCF 3-Yr CAGR
77.99%
Per Share Metrics
EPS (Diluted)
$3.92
EPS (Basic)
$3.98
Dividends / Share
N/A
Book Value / Share
$33.69
EPS YoY Growth
422.67%
Balance Sheet (FY 2025)
Total Assets
$65.43M
Total Liabilities
$333.59M
Stockholders' Equity
$4.57B
Current Assets
$65.43M
Current Liabilities
$333.59M